| 12338285 |
Anti-FcRn antibodies |
Alastair David Griffiths Lawson, Stevan Graham Shaw, Bryan John Smith, Kerry Louise Tyson, Lara Kevorkian +3 more |
2025-06-24 |
| 12331117 |
Antibody molecules which bind CD22 |
Stephen Edward Rapecki, Kerry Louise Tyson, Michael John Wright |
2025-06-17 |
| 11692041 |
Antibody molecules which bind CD45 |
Stephen Edward Rapecki, Kerry Louise Tyson, Michael John Wright |
2023-07-04 |
| 11472879 |
Antibody molecules which bind CD22 |
Stephen Edward Rapecki, Kerry Louise Tyson, Michael John Wright |
2022-10-18 |
| 11384148 |
Anti-FcRn antibodies |
Alastair David Griffiths Lawson, Stevan Graham Shaw, Bryan John Smith, Kerry Louise Tyson, Lara Kevorkian +3 more |
2022-07-12 |
| 11261252 |
Molecules with specificity for CD79 and CD22 |
Stephen Edward Rapecki, Michael John Wright, Kerry Louise Tyson |
2022-03-01 |
| 11220547 |
Antibodies specific to FCRN |
Paul Alan Atherfold, Thomas Allen Ceska, Lara Kevorkian, Kaushik Sarkar, Bryan John Smith +1 more |
2022-01-11 |
| 10954312 |
Method employing bispecific protein complex |
— |
2021-03-23 |
| 10774152 |
Molecules with specificity for CD45 and CD79 |
Stephen Edward Rapecki, Michael John Wright, Kerry Louise Tyson |
2020-09-15 |
| 10618957 |
Antibody molecules which bind CD79 |
Stephen Edward Rapecki, Kerry Louise Tyson, Michael John Wright |
2020-04-14 |
| 10590197 |
Antibody molecules which bind CD22 |
Stephen Edward Rapecki, Kerry Louise Tyson, Michael John Wright |
2020-03-17 |
| 10370447 |
Molecules with specificity for CD79 and CD22 |
Stephen Edward Rapecki, Michael John Wright, Kerry Louise Tyson |
2019-08-06 |
| 10358493 |
Bispecific format suitable for use in high-through-put screening |
Stephen Edward Rapecki, Michael John Wright |
2019-07-23 |
| 10273302 |
Antibodies specific to FcRn |
Paul Alan Atherfold, Thomas Allen Ceska, Lara Kevorkian, Kaushik Sarkar, Bryan John Smith +1 more |
2019-04-30 |
| 10233243 |
Anti-FcRn antibodies |
Alastair David Griffiths Lawson, Stevan Graham Shaw, Bryan John Smith, Kerry Louise Tyson, Lara Kevorkian +3 more |
2019-03-19 |
| 10112996 |
Function modifying NAv1.7 antibodies |
Terence Seward Baker, Alastair David Griffiths Lawson, Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff |
2018-10-30 |
| 9840556 |
Anti-TNF alpha antibodies which selectively inhibit TNF alpha signalling through the p55R |
Derek Thomas Brown, Hishani Kirby, Alastair David Griffiths Lawson |
2017-12-12 |
| 9738710 |
Method of treating a patient for pain by administering an anti-ion channel antibody |
Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff, Alastair David Griffiths Lawson, Terence Seward Baker |
2017-08-22 |
| 9266953 |
Methods of treating pain using function modifying NAv1.7 antibodies |
Terence Seward Baker, Alastair David Griffiths Lawson, Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff |
2016-02-23 |
| 8986954 |
DNA encoding function modifying Nav1.7 antibodies |
Terence Seward Baker, Alastair David Griffiths Lawson, Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff |
2015-03-24 |
| 8926977 |
Antibodies to the E1 extracellular loop of ion channels |
Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff, Alastair David Griffiths Lawson, Terence Seward Baker |
2015-01-06 |
| 8734798 |
Function modifying NAv 1.7 antibodies |
Terence Seward Baker, Alastair David Griffiths Lawson, Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff |
2014-05-27 |
| 7052876 |
Combinatorial method for producing nucleic acids |
Alastair David Griffiths Lawson |
2006-05-30 |
| 7052906 |
Synthetic transmembrane components |
Alastair David Griffiths Lawson |
2006-05-30 |